Farmakokinetik/Pharmakodinamik korelasyon Amantadinin Levodopa-İndüklenmiş Dyskinezi için analizi.
Pharmacokinetic/Pharmacodynamic Correlation Analysis of Amantadine for Levodopa-Induced Dyskinesia.
DOI: 10.1124/jpet.118.247650PMID: 30087157
Pharmacokinetic/Pharmacodynamic Correlation Analysis of Amantadine for Levodopa-Induced Dyskinesia.
DOI: 10.1124/jpet.118.247650PMID: 30087157
The potential price and access implications of the cost-utility and budget impact methodologies applied by NICE in England and ICER in the US for a novel gene therapy in Parkinson's disease.
DOI: 10.1080/20016689.2018.1500419PMID: 30364868
Additive Effects of Levodopa and a Neurorestorative Diet in a Mouse Model of Parkinson's Disease.
DOI: 10.3389/fnagi.2018.00237PMID: 30127735
Rotigotine transdermal patch for the treatment of neuropsychiatric symptoms in Parkinson's disease: A meta-analysis of randomized placebo-controlled trials.
DOI: 10.1016/j.jns.2018.08.003PMID: 30099246
CADTH Canadian Drug Expert Committee Recommendation: Levodopa/Carbidopa Intestinal Gel (Duodopa — Abbvie Corporation): Indication: Parkinson’s disease
PMID: 30942988
Anti-Tumor Necrosis Factor Therapy and Incidence of Parkinson Disease Among Patients With Inflammatory Bowel Disease.
DOI: 10.1001/jamaneurol.2018.0605PMID: 29710331
Update in therapeutic strategies for Parkinson's disease.
DOI: 10.1097/wco.0000000000000579PMID: 29746402
Deep brain stimulation for the treatment of disorders of consciousness and cognition in traumatic brain injury patients: a review.
DOI: 10.3171/2018.5.focus18168PMID: 30064315
Amantadine Extended-Release (GOCOVRI<sup>™</sup>): A Review in Levodopa-Induced Dyskinesia in Parkinson's Disease.
DOI: 10.1007/s40263-018-0552-2PMID: 30088203
Superoxide Radical Dismutation as New Therapeutic Strategy in Parkinson's Disease.
DOI: 10.14336/ad.2017.1018PMID: 30090659
Current surgical treatments for Parkinson's disease and potential therapeutic targets.
DOI: 10.4103/1673-5374.235220PMID: 30106037
Erratum: A practical approach to detection and treatment of depression in Parkinson disease and dementia.
DOI: 10.1212/cpj.0000000000000478PMID: 30140576
Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.